US 11234994
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted A61KA61K31/7105A61K31/713
Quick answer
US patent 11234994 (Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof) held by Benitec Biopharma Limited expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Benitec Biopharma Limited
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/7105, A61K31/713, A61K48/005, A61P